Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
151,803,139
-
Total 13F shares
-
81,040,169
-
Share change
-
+2,914,792
-
Total reported value
-
$2,492,288,624
-
Put/Call ratio
-
95%
-
Price per share
-
$30.90
-
Number of holders
-
115
-
Value change
-
+$38,865,286
-
Number of buys
-
79
-
Number of sells
-
70
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q3 2019
As of 30 Sep 2019,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,040,169 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, Senator Investment Group LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TIGER MANAGEMENT L.L.C., TimesSquare Capital Management, LLC, FRED ALGER MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.